Katalog GES



Healthcare innovation and patent law's 'pharmaceutical privilege': is there a pharmaceutical privilege? And if so, should we remove it?

This article reviews current trends in patent claims regarding personalised, stratified and precision medicine. These trends are not particularly well understood by policymakers, even less by the public, and are quite recent. Consequently, their implications for the public interest have hardly... Full description

1st Person: Graham Dutfield
Source: in Health economics, policy and law Vol. 12, No. 4 (2017), p. 453
More Articles
Type of Publication: Article
Language: English
Published: 2017
Online: Volltext
https://search.proquest.com/docview/1935406556
  Search for full text

Similar Items

Cannot find similar records

Library Services

Search Options

Quick links

Orientation